Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02765854
Title Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized With NFKB2 Rearrangement
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Emory University
Indications

multiple myeloma

Therapies

Dexamethasone + Ixazomib + Lenalidomide

Dexamethasone + Ixazomib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Grady Memorial Hospital Recruiting Atlanta Georgia 30303 United States Details
Emory University/Winship Cancer Institute Recruiting Atlanta Georgia 30322 United States Details
University of Michigan/Rogel Cancer Center Recruiting Ann Arbor Michigan 48109 United States Details
Washington University/Siteman Cancer Center Recruiting Saint Louis Missouri 63110 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field